https://www.selleckchem.com/products/XAV-939.html
Parechovirus A3 (PeVA3) was first reported in 2004 and has been recognized as a causative agent of mild and severe infectious diseases among children. We first reported an outbreak of adult PeVA3-associated myalgia (PeVA3-M) in Yamagata, Japan in 2008. We have repeatedly observed PeVA3-M cases in 2011, 2014, and 2016, and identified the first child case in 2014. Reports of PeVA3-M have increased since 2014, indicating that recognition of PeVA3-M has spread across Japan. Findings showed that PeVA3-M commonly occurs among adults aged 30-4